Replies to post #167591 on Value Microcaps Motherboard

[Bobwins]

Looked at Biorem at about the same time as LM. Saw the FD eps is .02 vs .05. Looked at report on Sedar and found they have near term expiration of convertible debt that could increase share count by 17million shares. There are 13.1 million shares outstanding and something called special warrants for another 6.9milllion shares of possible issuance.

All together, FD share count is 38.1 million vs the stated outstanding of 13.1million.

I agree that LM will have more trouble gaining ground with 10 million potential shares that could be sold now but sometime during the next year, BRM.v will have some kind of big share issuance, too.

I like the confirmed backlog of BRM vs the hope that LM can continue recent sales levels. However IF LM can grow sales, their gross margins are big and should lead to increased net profits on an actual and FD eps levels.

Both seem undervalued. I don't have a lot of cash but am considering adding some BRM.v along with the LM.v I bought yesterday.

Good luck, Bobwins